The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Background {#s1}
==========

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multi-system illness characterized by reduced functioning associated with fatigue that is not due to ongoing exertion and not significantly improved by rest. Minimal mental or physical exertion may trigger relapse (termed post-exertional malaise). Additional core or common symptoms include unrefreshing sleep, cognitive problems, increased symptoms when standing, and pain, but patients may experience numerous other symptoms ([@B1]--[@B4]). Several different etiologies have been investigated for ME/CFS but so far the etiology cannot be fully explained ([@B4], [@B5]). Experts have noted that the terminology "chronic fatigue syndrome" can trivialize this illness and stigmatize persons who experience its symptoms ([@B6]). A variety of other names have been used, including myalgic encephalomyelitis (ME), ME/CFS, chronic fatigue immune dysfunction, and most recently, systemic exertion intolerance disease ([@B4]). In 2010, the Chronic Fatigue Syndrome Advisory Committee recommended use of ME/CFS across federal agencies within the Department of Health and Human Services. The term ME/CFS will be used in this paper.

Previous prevalence estimates of ME/CFS have varied from 0.007 to 8.34% ([@B7]--[@B16]). In the community-based studies (with or without clinical assessment), the prevalence of ME/CFS was estimated to be 0.007--8.34%, and in the clinical-based studies in primary care setting the prevalence was estimated to be 0.006--3.00%. The large variation in the ME/CFS prevalence estimates may be due to differences in study methodology, such as study population composition, heterogeneity of source populations, data collection procedures, limitations in case ascertainment, different case definitions, and operational application of case definition criteria. Moreover, most prior studies took place at a small number of hospitals or clinics, or used a population sample from one state ([@B9], [@B11], [@B13], [@B17], [@B18]).

The economic burden and functional impairment associated with ME/CFS is substantial and comparable to heart disease and multiple sclerosis. ME/CFS accounts for \$18--51 billion of economic costs including \$9--14 billion in medical costs and \$9--37 billion in lost productivity annually ([@B19]--[@B21]). Patients with ME/CFS suffer from worse functional impairment compared to cancer, diabetes, heart disease, lung disease, multiple sclerosis, and rheumatoid arthritis ([@B15], [@B22]). Additionally, many patients with ME/CFS are found to have additional overlapping pain conditions such as fibromyalgia, multiple chemical sensitivity, and irritable bowel syndrome ([@B23]--[@B27]). Adjusting to a chronic, debilitating illness sometimes leads to other problems, including depression, stress, and anxiety. Like patients with other chronic illnesses, many patients with ME/CFS develop depression during their illness course ([@B28], [@B29]). ME/CFS patients with other co-morbid conditions have poor health and worse functioning status than those without co-morbid conditions. Co-morbid or co-existing conditions may also increase the frequency of healthcare utilization including office visits and laboratory tests ([@B27], [@B30]) and further complicate the management of ME/CFS symptoms. Many ME/CFS patients do not receive appropriate healthcare, partially due to constraints US healthcare systems face in addressing chronic illnesses but also due to healthcare providers lack of knowledge and misaligned attitudes, and beliefs concerning ME/CFS ([@B31], [@B32]).

In this study, we sought to use US national healthcare data from ambulatory visits to evaluate trends from 2000 to 2009 in ME/CFS. Additionally, we characterized demographics, co-morbidities, and healthcare services/quality indicators related to ME/CFS visits.

Methods {#s2}
=======

Data Sources
------------

This analysis was based on the National Ambulatory Medical Care Survey (NAMCS) ([@B33]) and the National Hospital Ambulatory Medical Care Survey (NHAMCS) ([@B34]) from 2000 to 2009. Since 1992, both surveys have been administrated by the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC) ([@B35]--[@B38]). The NCHS Research Ethics Review Board approved the protocols for both the NAMCS and NHAMCS surveys, including a waiver of the requirement for informed consent of participating patients.

In brief, NAMCS collects healthcare data provided by non-federal office-based physicians whereas NHAMCS collects healthcare data provided by non-federal hospital outpatient departments (OPDs) and hospital emergency departments (EDs). Both surveys use multistage probability sampling procedures to allow for generating nationally representative estimates of ambulatory medical care services in the United States. The patient visit was the unit of this analysis. Between 2000 and 2009, response rates were 58.9--70.4% among physicians invited to participate in NAMCS, 68.3--91.0% among hospital OPDs, and 79.5--97.0% among EDs invited to participate in NHAMCS.

This analysis included the aggregated number of 748,464 adult visits (made by patients aged 18 years or older, 9.06 billion weighted visits) from the NAMCS and NHAMCS data during 2000--2009. This included 231,984 physician patient visits (7.49 billion weighted visits), 250,821 OPD visits (691 million weighted visits), and 265,659 ED visits (879 million weighted visits).

Measures
--------

The US national ambulatory data includes up to three listed diagnoses (primary, secondary, and tertiary) for each visit. We classified all visits into two types: ME/CFS-related visits and non-ME/CFS-related visits. ME/CFS-related visits were identified using the International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) code, 780.71, up to tertiary diagnosis received in provider\'s diagnoses during visits. The primary outcomes of interest were: (1) co-morbidities, (2) healthcare services. We also examined the associations between types of visits and patient demographics.

### Co-morbidities

In addition to the provider\'s diagnoses for patient visits, providers (for NAMCS and OPD only for NHAMCS) indicate the presence of 14 conditions even if the condition had been reported in the diagnosis box. The 14 conditions were arthritis, asthma, cancer, cerebrovascular disease, congestive heart failure, chronic renal failure, chronic obstructive pulmonary disease, depression, diabetes, hyperlipidemia, hypertension, ischemic heart disease, obesity, and osteoporosis. We considered these to be co-morbid conditions, and compared the percentages of ME/CFS and non-ME/CFS-related visits with these conditions.

### Healthcare Services

Both NAMCS and NHAMCS surveys collected information on any service ordered or provided for patients during their visits. Our analysis included three categories of healthcare services: (1) preventive counseling/management services---asthma, diet/nutrition, exercise, family planning/contraception, growth/development, injury prevention, stress management, tobacco use/exposure, weight reduction, and other counseling, (2) diagnostic/screening services---complete blood count (CBC), glucose, glycohemoglobin (HgbA1c), lipid/cholesterol, and other blood tests, and (3) non-medication treatments---Complementary Alternative Medicine (CAM), physical therapy, psychotherapy, and other mental health counseling. We also examined the length of the patient\'s visit. These healthcare services have been constructed as quality indicators in other illnesses along with other illness-specific quality indicators based on the Institute of Medicine\'s broad criteria of clinical importance, scientific soundness, and feasibility for indicator selection ([@B39], [@B40]).

Other variables used in this study were: (1) patient demographics- age, sex, race/ethnicity, source of payment source including insurance type, and tobacco use (current or not), (2) vital signs---body mass index (BMI), and blood pressure (BP), and (3) physician/clinic information---geographic region (Northeast/Midwest/South/West), metropolitan statistical area (MSA or not), physician specialty (NAMCS only), clinic type (OPD only), physician practice characteristics (NAMCS only; solo practitioner physician practice characteristics employment status, ownership, office type), use of electronic medical records (EMRs), and referral status.

Statistical Analysis
--------------------

Statistical analyses were performed using STATA version 12 (Stata Corporation, College Station, TX). To report national estimate, the "svy" command designed for multistage weighted probability surveys such as NAMCS and NHAMCS were utilized. The NCHS analytical guidelines establish the legitimacy of combining multiple years of data from the NAMCS and NHAMCS surveys. Comparisons of NAMCS and NHAMCS suggested limited differences in the percentage estimates of ME/CFS-related visits annually. We, therefore, combined the two surveys for subsequent analyses between ME/CFS-related and non-ME/CFS-related visits.

The Pearson correlation test was used to analyze the percentage trend of ME/CFS-related visits during 2000--2009. In addition to national estimate of ME/CFS-related visits, we examined bivariate associations of ME/CFS-related visits with the following health and healthcare outcomes: (1) co-morbidities, (2) quality of healthcare such as health education services and length of patient\'s visit, (3) other variables such as patient and physician/clinic information, and vital signs.

Results {#s3}
=======

Demographic Characteristics of ME/CFS-Related Visits
----------------------------------------------------

[Table 1](#T1){ref-type="table"} shows the demographics for overall visits to physician offices, hospital outpatient departments, and emergency departments. Among 784,464 visits made by patients ≥18 years of age in the 2000--2009 NAMCS and NHAMCS datasets, we identified 130 visits (unweighted counts) indicating ICD-9-CM code, 780.71 for ME/CFS. After appropriate weighting, the estimated number of visits made by patients with ME/CFS in the United States over the 10 years period was 2.9 million \[95% Confidence interval (CI): 1.8--3.9 million\]. ME/CFS patient visits were mostly in the fourth and fifth decade age group (48.76%), female (66.07%), white (86.95%), metropolitan/urban residents (92.04%), and insured (87.26%). There were no statistically significant difference on the distribution of age, sex, race, residential area, and insurance between ME/CFS and non-ME/CFS related visits. Of the ME/CFS-related visits to office-based physicians, 52.12% were to general/family practitioners and internists. Obstetrics and gynecology, psychiatry, and neurology combined only accounted for \<10% while all other specialties accounted for 38.13% ME/CFS patient visits. Among ME/CFS-related visits to hospital outpatient departments, general medicine clinics accounted for most of the visits (72.38%). Compared to non-ME/CFS visits, a slightly higher rate of adopting electronic health record (EHR) systems was observed in ME/CFS-related visits (35.91 vs. 42.95%).

###### 

Patient and practice demographic characteristics of ambulatory adult visits in USA, 2000--2009.

  **Variables**                           **All visits**           **ME/CFS visits**    **Non-ME/CFS visits**    ***P*-value[^**a**^](#TN1){ref-type="table-fn"}**
  --------------------------------------- ------------------------ -------------------- ------------------------ ---------------------------------------------------
  Unweighted no. of visits                748,464                  130                  748,334                  
  Weighted no. of visits                  9,061,664,246            2,911,161            9,058,753,085            
  Practice setting (%)                                                                                           
     Office based (NAMCS)                 7,491,099,961 (82.67%)   2,723,988 (93.57%)   7,488,375,973 (82.66%)   
     Outpatient department (NHAMCS-OPD)   690,679,940 (7.62%)      119,850 (4.12%)      690,560,090 (7.62%)      
     Emergency department (NHAMCS-ED)     879,884,345 (9.71%)      67,323 (2.31%)       879,817,022 (9.71%)      
  Physician Specialty^1^ (%)                                                                                     0.382
     General and family practice          24.97%                   35.86%               24.97%                   
     Internal medicine                    18.82%                   16.26%               18.82%                   
     Obstetrics and gynecology            9.33%                    2.06%                9.33%                    
     Psychiatry                           3.15%                    4.72%                3.15%                    
     Neurology                            1.56%                    2.96%                1.56%                    
     All other                            42.18%                   38.13%               42.18%                   
  Clinical Type^2^ (%)                                                                                           0.001
     General medicine                     65.75%                   72.38%               65.75%                   
     Surgery                              13.48%                   16.03%               13.48%                   
     Pediatric                            1.06%                    0.00%                1.06%                    
     Obstetrics and Gynecology            10.45%                   0.13%                10.45%                   
     Substance abuse                      0.92%                    0.00%                0.92%                    
     Other                                8.34%                    11.46%               8.34%                    
                                          (n: 6,075,856,067)       (n: 1,673,624)       (n: 6,074,182,443)       
  EHR use^3^ (%)                          35.91%                   42.95%               35.91%                   0.462
  Age, mean (SD)                          52.65 (18.89)            48.56 (11.60)        52.66 (18.89)            0.077
  Age, median (range)                     47 (18--100)             47.5(20--89)         47 (18--100)             
  Age Group (%)                                                                                                  0.440
     18 to 29                             13.81%                   15.22%               13.81%                   
     30 to 39                             13.90%                   11.46%               13.90%                   
     40 to 49                             17.02%                   31.44%               17.02%                   
     50 to 59                             17.81%                   17.32%               17.81%                   
     60 to 69                             15.06%                   12.01%               15.06%                   
     70 or older                          22.40%                   12.56%               22.40%                   
  Sex (%)                                                                                                        0.528
     Female                               61.35%                   66.07%               61.35%                   
  Race (%)                                                                                                       0.800
     White                                83.87%                   86.95%               83.87%                   
     Black                                11.81%                   9.21%                11.81%                   
     Other                                4.32%                    3.84%                4.32%                    
  Metropolitan status: (MSA) (%)          85.79%                   92.04%               85.79%                   0.140
  Geographic region (%)                                                                                          0.499
     Northeast                            20.56%                   15.99%               20.56%                   
     Midwest                              22.43%                   19.88%               22.43%                   
     South                                36.66%                   32.54%               36.67%                   
     West                                 20.34%                   31.59%               20.34%                   
  Health insurance (%)                                                                                           0.077
     Private                              49.94%                   59.62%               49.94%                   
     Medicare                             27.04%                   24.65%               27.04%                   
     Medicaid                             8.07%                    2.99%                8.08%                    
     Other                                14.94%                   12.74%               14.94%                   

*1. NAMCS only; 2. OPD only; 3. 03-09 NAMCS and 05-09 OPD/ED*.

*p-values based on adjusted Wald tests with H~0~, Var\|~if\ ME/CFS~ = Var\|~if\ NON−ME/CFS~; Column percentages were listed in the table*.

ME/CFS Patient Visit Trend, 2000--2009
--------------------------------------

Overall 0.03% of ambulatory visits by patients aged 18 years or older were made by ME/CFS patients. The percentage of ME/CFS-related visits was 0.04% for physician office visits, 0.02% for OPD visits, and 0.01% for ED visits. These proportions did not change significantly over time. The percentage of ME/CFS-related visits ranged from 0.02 to 0.08% during 2000--2009, and there was no statistical evidence for a linearly increasing trend across year (*p*-value for the linear trend: 0.31) ([Figure 1](#F1){ref-type="fig"}).

![ME/CFS patient visit trend, 2000−2009.](fped-07-00185-g0001){#F1}

Vital Signs, Continuity of Care, Providers Seen, and Visit Disposition
----------------------------------------------------------------------

[Table 2](#T2){ref-type="table"} summarizes the information on vital signs, continuity of care, major reason for visits, providers seen, and visit disposition of ME/CFS and non-ME/CFS patients. The vital signs of patients visiting for ME/CFS and all others did not differ significantly. The number of visits during the past 12 months made by established ME/CFS patients was greater than that by non-CFS patients (5.60 vs. 4.35, *p* = 0.202). Of ME/CFS-related visits, the top three reasons for visits were chronic/routine problems (60.85%), new problems (14.86%), and chronic/flare up problems (11.47%). Physicians provided care for over 90% of the patient visits for both ME/CFS-related and non-ME/CFS visits. The rates of referral to other physicians did not differ significantly between ME/CFS-related and non-ME/CFS visits.

###### 

Vital sign and continuity of care ambulatory adult visits in USA, 2000--2009.

  **Variables**                                      **All visits**        **ME/CFS visits**      **Non-ME/CFS visits**   ***P*-value[^**a**^](#TN2){ref-type="table-fn"}**
  -------------------------------------------------- --------------------- ---------------------- ----------------------- ---------------------------------------------------
  Unweighted no. of visits                           748,464               130                    748,334                 
  Weighted no. of visits                             9,061,664,246         2,911,161              9,058,753,085           
  Vital sign                                                                                                              
     Body Mass Index (BMI)^1^, mean (SD)             29.13 (7.18)          27.42 (4.60)           29.13 (7.18)            0.274
     Body Mass Index (BMI)^1^, median (range)        28.19 (8.14--98.91)   28.25 (19.66--51.58)   28.19 (8.14--98.91)     
     Blood Pressure (systolic)^2^, mean (SD)         128.22 (19.52)        126.38 (11.96)         128.22 (19.52)          0.607
     Blood Pressure (systolic)^2^, median (range)    129 (0--290)          121.5 (89--180)        129 (0--290)            
     Blood Pressure (diastolic)^2^, mean (SD)        76.16 (11.97)         75.72 (6.97)           76.16 (11.97)           0.803
     Blood Pressure (diastolic)^2^, median (range)   76 (0--190)           76 (37--109)           76 (0--190)             
  Current tobacco user^3^ (%)                        11.51%                12.77%                 11.51%                  0.811
  Continuity of care                                                                                                      
     Established patient^4^ (%)                      87.04%                87.17%                 87.04%                  0.981
       \# of visits^5^, mean (SD)                    4.35 (6.29)           5.60 (3.80)            4.35 (6.29)             0.202
       \# of visits^5^, median (range)               2 (0--99)             4 (0--21)              2(0--99)                
       Prior-visit status^6^                                                                                              0.144
         None                                        8.64%                 3.60%                  8.64%                   
         1--2 visits                                 34.36%                29.53%                 34.37%                  
         3--5 visits                                 24.43%                17.04%                 24.43%                  
         6 or more visits                            32.57%                49.83%                 32.57%                  
       New patient^4^                                                                                                     0.306
     Referred for this visit (%)                     17.01%                10.08%                 17.02%                  
     Not referred for this visit (%)                 33.34%                44.86%                 33.34%                  
     Unknown if referred (%)                         49.65%                45.06%                 49.65%                  
  Major reason for this visit^4^                                                                                          0.007
     Chronic problem, routine                        35.21%                60.85%                 35.21%                  
     New problem                                     32.17%                14.86%                 32.18%                  
     Chronic problem, flare up                       9.08%                 11.47%                 9.08%                   
     Preventive care                                 16.15%                9.55%                  16.15%                  
     Pre-/Post-surgery                               7.39%                 3.26%                  7.39%                   
  Providers at this visit                                                                                                 
     Physician                                       94.21%                91.14%                 94.21%                  0.570
     Physician assistant                             3.94%                 2.62%                  3.94%                   0.434
     Nurse practitioner/Midwife                      2.10%                 0.00%                  2.10%                   0.000
     RN/LPN                                          34.09%                29.79%                 34.09%                  0.537
     Other                                           23.57%                32.09%                 23.57%                  0.284
     Mental health provider^7^                       0.55%                 0.00%                  0.55%                   0.002
  Visit disposition^3^                                                                                                    
     Refer to other physician                        8.06%                 9.89%                  8.06%                   0.698

*1. 05-09 NAMCS/OPD; 2. 03-09 NAMCS/OPD/ED; 3. 01-09 NAMCS/OPD; 4. 00-09 NAMCS/OPD; 5. 01-09 NAMCE/OPD and 07-09 ED; 6. 07-09 NAMCS/OPD/ED; 7. 07-09 NAMCS/OPD*.

*p-values based on adjusted Wald tests with H~0~, Var\|~if\ ME/CFS~ = Var\|~if\ NON−ME/CFS~; Column percentages were listed in the table*.

ME/CFS and Other Chronic Conditions as Co-morbidities
-----------------------------------------------------

[Table 3](#T3){ref-type="table"} shows chronic conditions recorded at ME/CFS-related and non-ME/CFS visits. The co-morbidity rate was higher in visits by patients with ME/CFS than those by patients without ME/CFS (71.30 vs. 61.18%). The most frequent chronic conditions among ME/CFS-related visits were depression (35.79%), hypertension (31.14%), diabetes (20.30%), arthritis (14.11%), and asthma (13.79%).

###### 

ME/CFS and co-morbid conditions.

  **Variables**                              **ME/CFS visits**   **Non-ME/CFS visits**   ***P*-value[^**a**^](#TN3){ref-type="table-fn"}**
  ------------------------------------------ ------------------- ----------------------- ---------------------------------------------------
     Unweighted no. of visits                130                 748,334                 
     Weighted no. of visits^1^               1,354,662           4,307,118,192           
  [Chronic Conditions]{.ul}                                                              
  \# of chronic conditions, mean (SD)        1.49 (1.05)         1.27 (1.40)             0.406
  \# of chronic conditions, median (range)   1 (0--6)            1 (0--13)               
  \# of chronic conditions (%)                                                           0.343
     No chronic condition                    28.70%              37.82%                  
     1 chronic condition                     19.19%              27.47%                  
     2 or more chronic conditions            52.11%              34.71%                  
     Depression                              35.79%              10.67%                  0.019
     Hypertension                            31.14%              30.66%                  0.965
     Diabetes                                20.30%              13.27%                  0.500
     Arthritis                               14.11%              15.83%                  0.799
     Asthma                                  13.79%              5.54%                   0.239
     Chronic obstructive pulmonary disease   12.90%              4.52%                   0.372
     Hyperlipidemia                          11.58%              17.65%                  0.443
     Cancer                                  6.59%               6.92%                   0.945
     Cerebrovascular disease                 1.64%               2.05%                   0.808
     Obesity                                 1.43%               8.13%                   0.002
     Osteoporosis                            0.11%               3.18%                   \<0.001
     Congestive heart failure                0.06%               2.20%                   \<0.001
     Chronic renal failure                   0.00%               1.84%                   \<0.001
     Ischemic heart disease                  0.00%               5.10%                   \<0.001

*1. 05-09 NAMCS/OPD*.

*p-values based on adjusted Wald tests with H~0~, Var\|~if\ ME/CFS~ = Var\|~if\ NON−ME/CFS~; Column percentages were listed in the table*.

Healthcare Services and Quality
-------------------------------

[Table 4](#T4){ref-type="table"} compares quality of healthcare between ME/CFS-related visits and non-ME/CFS related visits. Physicians spent more time for ME/CFS-related visits than non-ME/CFS visits (23.62 vs. 19.38 min, *p* = 0.065). Fewer health counseling services were provided in ME/CFS-related visits than non-ME/CFS related visits (0.16 vs. 0.32 services per visit, *p* = 0.126). The most common counseling services provided during visits by ME/CFS patients were diet/nutrition (8.33%), exercise (8.21%), and smoking cessation (7.24%). Compared to non-ME/CFS visits, a lower proportion of ME/CFS-related visits was provided health education services on stress management (0.75 vs. 3.14%, *p* = 0.010), weight reduction (0.88 vs. 4.02%, *p* = 0.002), injury prevention (0.04 vs. 1.64%, *p* \< 0.001), and family planning/contraception (0.17 vs. 1.45%, *p* = 0.037). Smoking cessation (tobacco use/expose) counseling was more prevalent in ME/CFS-related visits than non-ME/CFS visits (7.24 vs. 2.89%, *p* = 0.386). Contrary to health counseling services, more diagnostic/screening tests were provided in ME/CFS-related visits than non-ME/CFS visits (1.00 vs. 0.50 services per visit, *p* = 0.132). The most common diagnostic/screening tests provided during visits by ME/CFS patients were CBC (25.01%), glucose (19.05%), and lipids/cholesterol (12.84%), but did not reach any statistical significance level of 0.05. Non-medication treatment was more frequently provided at ME/CFS-related visits than non-ME/CFS visits (0.15 vs. 0.07 per visit, *p* = 0.244).

###### 

Quality indicators of healthcare between ME/CFS-related and non-ME/CFS related visits.

  **Variables**                                         **ME/CFS visits**   **Non-ME/CFS visits**   ***P*-value[^**a**^](#TN4){ref-type="table-fn"}**
  ----------------------------------------------------- ------------------- ----------------------- ---------------------------------------------------
     Unweighted no. of visits                           130                 748,334                 
     Weighted no. of visits                             1,354,662           4,307,118,192           
  [Time Spent with Physician]{.ul}^1^, mean (SD)        23.62 (14.86)       19.38 (13.83)           0.065
  [Time Spent with Physician]{.ul}^1^, median (range)   20 (0--90)          15 (0--240)             
  [Health Education Services]{.ul}^2^                                                               
     \# of services ordered, mean (SD)                  0.16 (0.57)         0.32 (0.74)             0.126
     \# of services ordered, median (range)             0 (0--3)            0 (0--5)                
     None (%)                                           92.00%              80.30%                  
     One (%)                                            0.21%               11.05%                  
     2 or more (%)                                      7.79%               8.65%                   
  Type of Health Education Services                                                                 
     Diet/Nutrition^3^                                  8.33%               12.48%                  0.306
     Exercise^3^                                        8.21%               9.79%                   0.677
     Weight reduction^4^                                0.88%               4.02%                   0.002
     Stress management^5^                               0.75%               3.14%                   0.010
     Tobacco use/exposure^5^                            7.24%               2.89%                   0.386
     Growth/Development^3^                              2.97%               0.54%                   0.412
     Asthma education^4^                                2.38%               0.91%                   0.531
     Injury prevention^7^                               0.04%               1.64%                   \<0.001
     Other health education^5^                          23.74%              19.86%                  0.702
     Family planning/Contraception^8^                   0.17%               1.45%                   0.037
  [Diagnostic/Screening Services]{.ul}^9^                                                           
     \# of services ordered, mean (SD)                  1.00 (1.51)         0.50 (1.06)             0.132
     \# of services ordered, median (range)             0 (0--5)            0 (0--5)                
     None (%)                                           57.73%              76.74%                  
     One (%)                                            20.32%              8.77%                   
     2 or more (%)                                      21.95%              14.49%                  
  Blood tests ordered: (%)                                                                          
     CBC^10^                                            25.01%              15.03%                  0.191
     Glucose^11^                                        19.05%              8.63%                   0.248
     HgbA1c^12^                                         3.24%               3.53%                   0.916
     Lipids/Cholesterol^13^                             12.84%              8.11%                   0.330
     Other blood test^14^                               33.94%              15.12%                  0.065
  [Non-Medication Treatment]{.ul}^5^                                                                
     \# of treatments ordered, mean (SD)                0.15 (0.36)         0.07 (0.27)             0.244
     \# of treatments ordered, median (range)           0 (0--2)            0 (0--3)                
     None (%)                                           84.78%              93.72%                  
     One (%)                                            15.17%              5.80%                   
     2 or more (%)                                      0.06%               0.48%                   
     CAM^7^                                             8.55%               1.09%                   0.125
     Physical therapy^5^                                2.70%               2.65%                   0.984
     Psychotherapy^3^                                   0.61%               2.24%                   0.003
     Other mental health counseling^5^                  0.06%               1.47%                   \<0.001

*1. 00-09 NAMCS and 00 OPD; 2. 05-09 NAMCS/OPD; 3. 00-09 NAMCS/OPD; 4. 01-09 NAMCS/OPD; 5. 05-09 NAMCS/OPD; 6. 05-09 NAMCS/OPD; 7. 00, 05-09 NAMCS/OPD; 8. 00 & 09 NAMCS/OPD; 9. 05-09 NAMCS/OPD and 03-04 ED; 10. 01-09 NAMCS/OPD and 00-09 ED; 11. 03-09 NAMCS/OPD and 01-09 ED; 12. 03-09 NAMCS/OPD and 01-04 ED; 13. 00-09 NAMCS/OPD and 01-04 ED; 14. 00, 05-09 NAMCS/OPD and 00, 03-09 ED*.

*p-values based on adjusted Wald tests with H~0~, Var\|~ifCFS~ = Var\|~ifNON−CFS~; Column percentages were listed in the table*.

Discussion {#s4}
==========

To our best knowledge, this is the first study that used a nationally representative healthcare sample of the U.S. to investigate the visit trend of diagnosing ME/CFS over years. This paper examined demographics, co-morbidities, and healthcare for visits by ME/CFS patients using a nationally representative sample of patient visits to physician offices, hospital outpatient departments, and emergency departments from 2000 to 2009. We found the overall estimated percentage of ME/CFS-related visits to be 0.03% with no statistical evidence (p-trend = 0.31) for a decline or increase from 2000 to 2009. Assuming no repeat visits by same patients, the percentage estimate of visits by ME/CFS patients would approximately reflect the prevalence estimates reported from previous studies in primary care settings.

Visits by ME/CFS patients report slightly more co-morbid conditions than visits by patients without ME/CFS. Over 70% of visits by ME/CFS patients report one or more co-morbid conditions, adding to complexity in ME/CFS healthcare. Our results on healthcare for visits by ME/CFS patients are mixed. While physicians spent more time during visits by ME/CFS patients than that by patients without ME/CFS, a lower portion of visits by ME/CFS patients was provided counseling for diet/nutrition, exercise, and weight reduction. On the other hand, a higher portion of visits by ME/CFS patients were provided diagnostic/screening tests and non-medication treatment twice as often as visits by non-ME/CFS patients.

Conclusion
----------

In conclusion, we found that there is no increasing or decreasing trend in the percentage of ME/CFS-related visits during 2000--2009. Compared to visits by non-ME/CFS patients, visits by ME/CFS patients are provided more direct care time by physicians, more diagnostic/screening tests, and more non-medication treatments but less health counseling services. Future research should consider developing basic guidelines or recommendations for appropriate healthcare in ME/CFS-diagnosed visits such as providing weight reduction or nutrient/diet counseling for ME/CFS patients with greater BMI. When providing exercise counseling, one should be cautious of the impact of exercise. An individualized exercise or activity management plan should be emphasized to balance rest and activity to avoid post-exertional malaise flare-ups. Before starting any individualized exercise or activity management program, one should be carefully assessed and monitored periodically on their muscle strength and functional status for any physical activity.

It will also allow for identifying the potential interrupted time series that might be resulted from future ICD coding transition/change and the impact of the 2015 IOM recommendation on ME/CFS. Future investigation on this topic is warranted.

Study Limitation
----------------

Several limitations of this study should be mentioned. First, NAMCS, and NHAMCS do not include identifiers for individual patients; therefore, some patients who made visits more than once may have had their visits counted independently, which would yield inaccurate estimates of the variance. The surveys used a randomly selected sampling unit (a physician or facility) with a reporting period of the randomly assigned 1-week for NAMCS and 4-week for NHAMCS. Although our results showed that on average ME/CFS patients made about 5.6 visits per year and that translated into one visit every 2 months, it\'s less likely that the same patient would visit to the same selected physician or facility during the randomly assigned 1-week reporting period. Therefore, we believe that this limitation might affect our conclusion only to a small degree. Second, the NAMCS and NHAMCS included at most only three diagnosis codes and chief complaints. A greater number of listed diagnosis codes was associated with a higher likelihood of identifying ME/CFS. Thus, we may not have been able to identify some ME/CFS patients who were diagnosed as ME/CFS in 4th or later diagnosis. There is an ICD-9-CM code 780.79 for "Other malaise and fatigue" which converts approximately to ICD-10-CM G93.3 for Postviral fatigue syndrome (\[Benign\] myalgic encephalomyelitis) but 780.79 was not commonly documented in this data source. Therefore, in our analysis we focused on visits with ICD-9-CM code, 780.71 for chronic fatigue syndrome. One should also be aware that the ME/CFS related visits might be under-reported due to the possibility of a substantial level of omissions by healthcare providers. Finally, due to the small number of cases identified one should be cautious of generalizing the results beyond the general healthcare setting.
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